Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABNB Airbnb	$126.55 +0.9%	$136.73	$110.38 ▼ $170.10	$79.79B	1.1	4.42 million shs	4.82 million shs
HLT Hilton Worldwide	$228.46 -1.5%	$254.16	$193.86 ▼ $275.22	$54.97B	1.29	1.66 million shs	3.36 million shs
HOTL Kelly Hotel & Lodging Sector ETF	$14.62	$14.62	$12.45 ▼ $15.50	$731K	1.17	278 shs	N/A
INVH Invitation Homes	$33.10 -2.3%	$31.78	$30.13 ▼ $37.80	$20.28B	1.03	3.08 million shs	2.25 million shs
MAR Marriott International	$243.81 -1.0%	$279.75	$204.55 ▼ $307.52	$67.22B	1.58	1.43 million shs	2.30 million shs
NTLA Intellia Therapeutics	$9.62 +3.4%	$10.48	$8.30 ▼ $28.88	$995.83M	1.97	3.32 million shs	1.62 million shs
REGN Regeneron Pharmaceuticals	$689.50 -4.0%	$696.62	$642.00 ▼ $1,211.20	$75.38B	0.27	621,957 shs	807,980 shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABNB Airbnb	-5.08%	-11.30%	-7.07%	-9.65%	-23.04%
HLT Hilton Worldwide	-3.12%	-10.94%	-14.16%	-9.96%	+13.34%
HOTL Kelly Hotel & Lodging Sector ETF	0.00%	0.00%	0.00%	0.00%	-0.01%
INVH Invitation Homes	-0.99%	-0.14%	+7.32%	+1.92%	-3.40%
MAR Marriott International	-4.24%	-9.04%	-18.97%	-15.57%	-0.87%
NTLA Intellia Therapeutics	-1.69%	+2.20%	-5.01%	-34.04%	-68.52%
REGN Regeneron Pharmaceuticals	-3.58%	+6.32%	+1.15%	-7.09%	-25.54%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABNB Airbnb	4.2507 of 5 stars	3.2	5.0	0.0	0.0	3.8	4.2	1.9
HLT Hilton Worldwide	4.3569 of 5 stars	2.2	4.0	1.7	2.5	3.6	2.5	1.9
HOTL Kelly Hotel & Lodging Sector ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INVH Invitation Homes	4.3475 of 5 stars	3.2	2.0	1.7	4.5	3.9	1.7	0.6
MAR Marriott International	4.5233 of 5 stars	3.2	3.0	1.7	1.3	3.4	3.3	1.9
NTLA Intellia Therapeutics	4.4592 of 5 stars	4.3	1.0	0.0	4.7	1.8	2.5	1.3
REGN Regeneron Pharmaceuticals	4.669 of 5 stars	4.4	3.0	1.7	2.3	2.0	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABNB Airbnb	2.32	Hold	$148.00	16.95% Upside
HLT Hilton Worldwide	2.40	Hold	$250.61	9.70% Upside
HOTL Kelly Hotel & Lodging Sector ETF	0.00	N/A	N/A	N/A
INVH Invitation Homes	2.35	Hold	$37.59	13.55% Upside
MAR Marriott International	2.35	Hold	$286.45	17.49% Upside
NTLA Intellia Therapeutics	2.63	Moderate Buy	$37.56	290.39% Upside
REGN Regeneron Pharmaceuticals	2.76	Moderate Buy	$973.13	41.13% Upside

Current Analyst Ratings Breakdown

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/12/2025	INVH Invitation Homes	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$36.00 ➝ $37.00
3/10/2025	ABNB Airbnb	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$165.00 ➝ $185.00
3/5/2025	INVH Invitation Homes	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$35.00 ➝ $36.00
3/5/2025	NTLA Intellia Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$30.00
3/4/2025	HLT Hilton Worldwide	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$265.00 ➝ $274.00
3/4/2025	MAR Marriott International	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$289.00 ➝ $298.00
3/4/2025	NTLA Intellia Therapeutics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$90.00 ➝ $50.00
2/28/2025	NTLA Intellia Therapeutics	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$55.00 ➝ $26.00
2/28/2025	NTLA Intellia Therapeutics	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$12.00 ➝ $14.00
2/28/2025	NTLA Intellia Therapeutics	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$60.00 ➝ $50.00
2/28/2025	NTLA Intellia Therapeutics	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $68.00

(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABNB Airbnb	$11.10B	7.19	$3.68 per share	34.35	$13.19 per share	9.59
HLT Hilton Worldwide	$11.17B	4.92	$6.97 per share	32.76	($15.40) per share	-14.83
HOTL Kelly Hotel & Lodging Sector ETF	N/A	N/A	N/A	N/A	N/A	N/A
INVH Invitation Homes	$2.62B	7.74	$2.03 per share	16.28	$16.65 per share	1.99
MAR Marriott International	$25.10B	2.68	$9.63 per share	25.32	($10.85) per share	-22.47
NTLA Intellia Therapeutics	$57.88M	17.21	N/A	N/A	$11.73 per share	0.82
REGN Regeneron Pharmaceuticals	$14.20B	5.31	$45.27 per share	15.23	$268.50 per share	2.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABNB Airbnb	$2.65B	$4.13	30.64	25.41	3.52	23.85%	32.29%	11.27%	5/14/2025 (Estimated)
HLT Hilton Worldwide	$1.54B	$6.15	37.15	24.91	2.86	13.74%	-54.47%	10.97%	4/23/2025 (Estimated)
HOTL Kelly Hotel & Lodging Sector ETF	N/A	N/A	23.63	∞	N/A	N/A	N/A	N/A	N/A
INVH Invitation Homes	$519.47M	$0.73	46.62	17.51	4.70	17.02%	4.36%	2.28%	4/29/2025 (Estimated)
MAR Marriott International	$2.38B	$8.32	29.30	20.84	3.42	9.46%	-116.67%	10.24%	4/29/2025 (Estimated)
NTLA Intellia Therapeutics	-$481.19M	-$5.25	N/A	N/A	N/A	N/A	-49.34%	-40.27%	5/8/2025 (Estimated)
REGN Regeneron Pharmaceuticals	$4.41B	$38.28	18.01	18.14	2.34	31.07%	16.32%	12.76%	5/1/2025 (Estimated)

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/26/2025	Q4 2024	INVH Invitation Homes	$0.47	$0.47	N/A	$0.47	$658.71 million	$659.13 million
2/13/2025	Q4 2024	ABNB Airbnb	$0.61	$0.73	+$0.12	$0.73	$2.42 billion	N/A
2/11/2025	Q4 2024	MAR Marriott International	$2.37	$2.45	+$0.08	$1.63	$6.40 billion	N/A
2/6/2025	Q4 2024	HLT Hilton Worldwide	$1.67	$1.76	+$0.09	$2.06	$2.77 billion	N/A
2/4/2025	Q4 24	REGN Regeneron Pharmaceuticals	$11.21	$12.07	+$0.86	$8.06	$3.76 billion	$3.79 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABNB Airbnb	N/A	N/A	N/A	N/A	N/A
HLT Hilton Worldwide	$0.60	0.26%	N/A	9.76%	N/A
HOTL Kelly Hotel & Lodging Sector ETF	$0.11	0.75%	N/A	N/A	N/A
INVH Invitation Homes	$1.16	3.50%	+18.45%	158.90%	N/A
MAR Marriott International	$2.52	1.03%	N/A	30.29%	N/A
NTLA Intellia Therapeutics	N/A	N/A	N/A	N/A	N/A
REGN Regeneron Pharmaceuticals	$0.88	0.13%	N/A	2.30%	N/A

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/13/2025	MAR Marriott International	quarterly	$0.63	0.87%	2/27/2025	2/27/2025	3/31/2025
2/6/2025	HLT Hilton Worldwide	Quarterly	$0.15	0.22%	2/21/2025	2/21/2025	3/28/2025
2/20/2025	REGN Regeneron Pharmaceuticals	quarterly	$0.88	0.53%	2/20/2025	2/20/2025	3/20/2025
12/13/2024	INVH Invitation Homes	quarterly	$0.29	3.5%	12/26/2024	12/26/2024	1/17/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABNB Airbnb	0.24	1.69	1.69
HLT Hilton Worldwide	N/A	0.70	0.70
HOTL Kelly Hotel & Lodging Sector ETF	N/A	N/A	N/A
INVH Invitation Homes	0.54	0.24	0.24
MAR Marriott International	N/A	0.40	0.40
NTLA Intellia Therapeutics	N/A	6.73	6.73
REGN Regeneron Pharmaceuticals	0.09	4.73	3.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABNB Airbnb	80.76%
HLT Hilton Worldwide	95.90%
HOTL Kelly Hotel & Lodging Sector ETF	N/A
INVH Invitation Homes	96.79%
MAR Marriott International	70.70%
NTLA Intellia Therapeutics	88.77%
REGN Regeneron Pharmaceuticals	83.31%

Insider Ownership

Company	Insider Ownership
ABNB Airbnb	27.83%
HLT Hilton Worldwide	2.50%
HOTL Kelly Hotel & Lodging Sector ETF	N/A
INVH Invitation Homes	0.28%
MAR Marriott International	12.32%
NTLA Intellia Therapeutics	3.20%
REGN Regeneron Pharmaceuticals	7.48%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABNB Airbnb	7,300	630.54 million	455.06 million	Optionable
HLT Hilton Worldwide	159,000	240.60 million	234.58 million	Optionable
HOTL Kelly Hotel & Lodging Sector ETF	N/A	50,000	N/A	Not Optionable
INVH Invitation Homes	1,555	612.69 million	610.89 million	Optionable
MAR Marriott International	377,000	275.70 million	241.73 million	Optionable
NTLA Intellia Therapeutics	600	103.52 million	98.59 million	Optionable
REGN Regeneron Pharmaceuticals	11,900	109.33 million	101.15 million	Optionable

NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Headlines

Recent News About These Companies

Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds?

March 12 at 2:57 PM | insidermonkey.com

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Boosted by Wealthfront Advisers LLC

March 12 at 5:46 AM | marketbeat.com

PNC Financial Services Group Inc. Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

March 12 at 4:16 AM | marketbeat.com

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem

March 11 at 11:01 PM | prnewswire.com

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem

March 11 at 9:32 PM | globenewswire.com

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Up 4.7% - What's Next?

March 11 at 4:17 PM | marketbeat.com

Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners 2025 Global Healthcare Conference Call Transcript

March 11 at 11:04 AM | seekingalpha.com

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

March 11 at 7:00 AM | accessnewswire.com

Cornerstone Advisors LLC Acquires 1,900 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

March 11 at 6:05 AM | marketbeat.com

Daiwa Securities Group Inc. Acquires 1,278 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

March 11 at 5:06 AM | marketbeat.com

Raymond James Financial Inc. Invests $65.18 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

March 11 at 4:01 AM | marketbeat.com

Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

March 10 at 8:18 PM | insidermonkey.com

Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

March 10 at 7:49 PM | msn.com

Regeneron Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 – REGN

March 10 at 6:00 PM | accessnewswire.com

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. ...

March 10 at 5:04 PM | gurufocus.com

REGN DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – REGN

March 10 at 4:47 PM | globenewswire.com

Regeneron Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 10, 2025 Deadline to file Lead Plaintiff Motion

March 10 at 4:40 PM | globenewswire.com

Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

March 10 at 4:15 PM | accessnewswire.com

Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. ...

March 10 at 2:40 PM | gurufocus.com

Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - March 10, 2025 Deadline to Join - Contact Levi & Korsinsky

March 10 at 2:00 PM | accessnewswire.com

Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. (REGN) of a Class Action Lawsuit and an Upcoming Deadline

March 10 at 1:05 PM | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
By Gabriel Osorio-Mazilli | February 14, 2025
View NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
Super Micro Computer’s Stock Is About to Make a Super Big Advance
By Thomas Hughes | February 12, 2025
View Super Micro Computer’s Stock Is About to Make a Super Big Advance
Palantir Stock Nears Bear Market Territory - Why and What’s Next?
By Chris Markoch | February 25, 2025
View Palantir Stock Nears Bear Market Territory - Why and What’s Next?
Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
By Thomas Hughes | March 6, 2025
View Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?

NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Company Descriptions

Airbnb NASDAQ:ABNB

$126.55 +1.11 (+0.88%)

Closing price 04:00 PM Eastern

Extended Trading

$126.92 +0.38 (+0.30%)

As of 07:43 PM Eastern

Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. The company's marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms, primary homes, and vacation homes. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010. Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Hilton Worldwide NYSE:HLT

$228.46 -3.37 (-1.45%)

Closing price 03:58 PM Eastern

Extended Trading

$229.00 +0.55 (+0.24%)

As of 07:38 PM Eastern

Hilton Worldwide Holdings Inc., a hospitality company, engages in managing, franchising, owning, and leasing hotels and resorts. It operates through two segments, Management and Franchise, and Ownership. The company engages in the hotel management and licensing of its brands. It operates luxury hotels under the Waldorf Astoria Hotels & Resorts, LXR Hotels & Resorts, and Conrad Hotels & Resorts brand; lifestyle hotels under the Canopy by Hilton, Curio Collection by Hilton, Tapestry Collection by Hilton, Tempo by Hilton, and Motto by Hilton brand; full service hotels under the Signia by Hilton, Hilton Hotels & Resorts, and DoubleTree by Hilton brand; service hotels under the Hilton Garden Inn, Hampton by Hilton, and Tru by Hilton brand; all-suite hotels under the Embassy Suites by Hilton, Homewood Suites by Hilton, and Home2 Suites by Hilton brand; and economy hotel under the Spark by Hilton brand, as well as Hilton Grand Vacations. The company operates in North America, South America, and Central America, including various Caribbean nations; Europe, the Middle East, and Africa; and the Asia Pacific. The company was founded in 1919 and is headquartered in McLean, Virginia.

Kelly Hotel & Lodging Sector ETF NYSEARCA:HOTL

$14.62 0.00 (0.00%)

As of 03/7/2025

The Kelly Hotel & Lodging Sector ETF (HOTL) is an exchange-traded fund that is based on the Strategic Hotel & Lodging Sector index, a market-cap-weighted index of hotel and lodging stocks from developed countries. HOTL was launched on Jan 12, 2022 and is managed by Kelly.

Invitation Homes NYSE:INVH

$33.10 -0.78 (-2.30%)

Closing price 03:58 PM Eastern

Extended Trading

$33.10 -0.01 (-0.02%)

As of 06:39 PM Eastern

Invitation Homes, an S&P 500 company, is the nation's premier single-family home leasing and management company, meeting changing lifestyle demands by providing access to high-quality, updated homes with valued features such as close proximity to jobs and access to good schools. The company's mission, Together with you, we make a house a home, reflects its commitment to providing homes where individuals and families can thrive and high-touch service that continuously enhances residents' living experiences.

Marriott International NASDAQ:MAR

$243.81 -2.50 (-1.01%)

Closing price 04:00 PM Eastern

Extended Trading

$244.46 +0.66 (+0.27%)

As of 07:18 PM Eastern

Marriott International, Inc. engages in operating, franchising, and licensing hotel, residential, timeshare, and other lodging properties worldwide. It operates its properties under the JW Marriott, The Ritz-Carlton, The Luxury Collection, W Hotels, St. Regis, EDITION, Bvlgari, Marriott Hotels, Sheraton, Westin, Autograph Collection, Renaissance Hotels, Le Méridien, Delta Hotels by Marriott, Tribute Portfolio, Gaylord Hotels, Design Hotels, Marriott Executive Apartments, Apartments by Marriott Bonvoy, Courtyard by Marriott, Fairfield by Marriott, Residence Inn by Marriott, SpringHill Suites by Marriott, Four Points by Sheraton, TownePlace Suites by Marriott, Aloft Hotels, AC Hotels by Marriott, Moxy Hotels, Element Hotels, Protea Hotels by Marriott, City Express by Marriott, and St. Regis Longboat Key brand names, as well as operates residences, timeshares, and yachts. The company was founded in 1927 and is headquartered in Bethesda, Maryland.

Intellia Therapeutics NASDAQ:NTLA

$9.62 +0.32 (+3.44%)

Closing price 04:00 PM Eastern

Extended Trading

$9.64 +0.02 (+0.16%)

As of 07:36 PM Eastern

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Regeneron Pharmaceuticals NASDAQ:REGN

$689.50 -28.66 (-3.99%)

Closing price 04:00 PM Eastern

Extended Trading

$688.64 -0.86 (-0.12%)

As of 07:59 PM Eastern

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Earnings

Compare Dividends

Latest NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NTLA, REGN, MAR, HLT, ABNB, INVH, and HOTL Company Descriptions

Airbnb NASDAQ:ABNB

Hilton Worldwide NYSE:HLT

Kelly Hotel & Lodging Sector ETF NYSEARCA:HOTL

Invitation Homes NYSE:INVH

Marriott International NASDAQ:MAR

Intellia Therapeutics NASDAQ:NTLA

Regeneron Pharmaceuticals NASDAQ:REGN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools